Holy smokes...Viking Therapeutics (NASDAQ:
VKTX) is up a
whopping 128% premarket on robust volume in response to its
announcement of positive results from a
Phase 2 clinical trial evaluating VK2809 in patients with
nonalcoholic fatty liver disease (NAFLD) and elevated low-density
lipoprotein cholesterol (LDL-C).
Holy smokes...Viking Therapeutics (NASDAQ: VKTX) is
Posted by morton7 on 18th of Sep 2018 at 08:18 am
Holy smokes...Viking Therapeutics (NASDAQ: VKTX) is up a whopping 128% premarket on robust volume in response to its announcement of positive results from a Phase 2 clinical trial evaluating VK2809 in patients with nonalcoholic fatty liver disease (NAFLD) and elevated low-density lipoprotein cholesterol (LDL-C).
VKTX - triple digit move
Posted by steve on 18th of Sep 2018 at 08:45 am
VKTX - triple digit move on that news
Playing this one with Options.
Posted by xxkumarxx on 18th of Sep 2018 at 09:26 am
Playing this one with Options. 12.50 Oct calls. going to sell on open
nice morning for ya!
Posted by matt on 18th of Sep 2018 at 09:42 am
nice morning for ya!
nice! congrats!
Posted by morton7 on 18th of Sep 2018 at 09:39 am
nice! congrats!